Quercetin, known for its strong antioxidant and anti-inflammatory properties (Shen et al., 2008), has been found to inhibit HSCs activation by affecting the NF-κB/MAPK and Bcl-2/BAX pathways, thereby delaying the progression of liver fibrosis. The gene discussed is BCL2; the disease is Hepatic fibrosis.